Oneness Biotech Co., Ltd. receives Israeli, Mexican and Hong Kong patents on the producing recombinant glycoproteins with modified glycosylation.

Published Date:2022-10-27

Statement
No	1	Date of announcement	2022/10/27	Time of announcement	17:02:31
Subject	Oneness Biotech Co., Ltd. receives Israeli, Mexican and Hong Kong patents on the producing recombinant glycoproteins with modified glycosylation.
To which item it meets	paragraph 53			Date of events	2022/10/27
Date of occurrence of the event: 111/10/27 Company name: ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter ”head office” or ”subsidiaries”): head office Reciprocal shareholding ratios: NA Cause of occurrence: The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein , has been granted Israeli, Mexican and Hong Kong patents entitled ” METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION” under the patent number 247776, 382334 and HK1238291, respectively. Countermeasures: None Any other matters that need to be specified: None